Pacific Biosciences Of California (PACB) Shares Outstanding (2010 - 2026)

Pacific Biosciences Of California has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $310.8 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 3.48% year-over-year to $310.8 million in Q2 2026; TTM through Jun 2026 was $310.8 million, a 3.48% increase from a year earlier, with the FY2025 full-year figure at $302.0 million, up 2.56% from the prior year.
• Shares Outstanding (Entity) was $310.8 million for Q2 2026 at Pacific Biosciences Of California, roughly flat from $310.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $310.8 million in Q2 2026, with the low at $224.3 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $270.4 million, with a median of $272.4 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) grew 2.5% in 2022, then rose 18.21% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $226.5 million in 2022, then grew by 18.21% to $267.7 million in 2023, then grew by 9.96% to $294.4 million in 2024, then advanced by 2.56% to $302.0 million in 2025, then gained by 2.93% to $310.8 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $310.8 million (Q2 2026), $310.5 million (Q1 2026), and $302.0 million (Q4 2025), per Business Quant data.